Texas Southern University, in partnership with University of Texas Medical Branch

Type of site

Health System, Pharmacy School

Texas Southern University (TSU) School of Pharmacy and Health Sciences, located in Houston, Texas, is a premier institution dedicated to training highly skilled professionals in pharmacy, health sciences, and related fields. As part of a historically Black University, the school is renowned for being the number one producer of Black pharmacists in the nation, reflecting its commitment to diversity, equity, and inclusion. Its Doctor of Pharmacy (Pharm.D.) program combines rigorous coursework with hands-on clinical experiences, preparing graduates to excel in various healthcare settings. TSU’s dedication to research, innovation, and addressing healthcare disparities underscores its vital role in advancing public health and fostering healthcare equity.

Texas Southern University is working in partnership with University of Texas Medical Branch (UTMB)

Videos

Advancing Research Innovation and Clinical Trial Equity | TSU

Site snapshot

CTAC Site:
Texas Southern University
3100 Cleburne Street
Houston, TX 77004

Clinical Research Location:
UTMB League City Campus
2240 Gulf Fwy S
League City, TX 77573

440* Patient Visits | 6* Licensed Beds | 11* Employees

*based on UTMB League City clinical location

Patient population in catchment area

Principal Investigator and site staff point of contact

Veronica Ajewole, PharmD, BCOP
Professor of Pharmacy Practice, College of Pharmacy and Health Sciences at Texas Southern University

713-313-1217
veronica.ajewole@tsu.edu

Mark Ibarra-Garza
Clinical Research Coordinator at Texas Southern University

713-313-1233
mark.ibarragarza@tsu.edu

General site information

Clinical research investigator and staff demographics

Research staff

Languages spoken by research staff

Spanish
English

Training

For PIs

Good Clinical Practice (GCP) Training
Required Training for Human Research
Additional Principal Investigator Training

For Coordinators/Staff

SOCRA certified

Total number of total potential principal investigators

Therapeutic areas of focus

Key

New

Existing

Addictive Behavior
Aging
Alzheimer's
Cancer
Cancer Prevention
COVID-19
Diabetes
Endocrinology
Hepatitis
Infectious Disease
Kidney & Urinary Tract
Neurology, Stroke, Alzheimer’s Disease, and Parkinson’s Disease
Obesity & Weight Management
Vaccines
Women’s Health

Clinical trial experience

Years of experience	While this site does not have experience conducting industry sponsored therapeutic trials, this site has conducted clinical research studies in the following non therapeutic areas: Oncology prevention and COVID-19
Phases of trials conducted	N/A
Number of trials conducted in past 2 years	N/A
Current rate of underrepresented participants in clinical research	N/A
Average retention rates	N/A

Clinical trial operations capabilities

(in partnership with UTMB)

Current research infrastructure

Dedicated research center space(s)
Investigational research pharmacy
Clinical pharmacy with research capability
Clinical research laboratory and processing capability
Clinical research imaging
Lab refrigerator
Centrifuge
Secure study supply storage
-80 freezer
-20 freezers
Temperature monitoring
Emergency power backup

Current technical infrastructure

CTMS
EHR(s)
eRegulartory system
Other Research Software(s)
Computer station
Secure printer

Average timelines

For internal approval of protocol

TBC

From receipt of trial materials to activation

TBC

Any prior FDA audit findings?

N/A

Use this form to take the next step with an CTAC site: request or submit CDAs, request review of protocols, or inquire about community input.